Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03947346
Study type Observational
Source Memorial Sloan Kettering Cancer Center
Contact
Status Active, not recruiting
Phase
Start date May 9, 2019
Completion date May 2025